Oakland, CA, United States of America

Kirk McLean

USPTO Granted Patents = 8 


Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Oakland, CA (US) (2007 - 2011)
  • Orinda, CA (US) (2013 - 2018)

Company Filing History:


Years Active: 2007-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Innovations of Kirk McLean

Introduction

Kirk McLean is a notable inventor based in Oakland, CA, with a significant contribution to the field of hematology. He holds a total of 8 patents, showcasing his dedication to advancing medical science and improving treatment options for patients with hematological diseases.

Latest Patents

Among his latest innovations are targeted coagulation factors and methods of using the same. These targeted coagulation factors comprise a coagulation factor linked with at least one domain that specifically binds to a membrane protein on a blood cell. The disclosed targeted coagulation factors increase the efficiency of coagulation factors and prolong their duration of action. This advancement represents a significant improvement for the treatment of hematological diseases such as hemophilia A.

Career Highlights

Kirk McLean has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Healthcare LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Some of his notable coworkers include David Richard Light and David Bruce Light. Their collaboration has likely played a role in the development of his innovative patents.

Conclusion

Kirk McLean's contributions to the field of hematology through his patents and collaborations highlight his commitment to improving patient care. His work continues to influence the treatment of hematological diseases, making a lasting impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…